antiviral news

Press Releases in the global landscape

Mar 24, 2026

ACP updates outpatient COVID-19 treatment guidance

The American College of Physicians updated outpatient COVID-19 treatment guidelines, outlining best practices for medication use in confirmed cases.

Mar 24, 2026

Japan approves preventive use of oral COVID drug Xocova in world first

Japan approved the preventive use of the oral COVID-19 antiviral Xocova, marking the first authorization of its kind globally.

Mar 23, 2026

Antiviral drug "Paquirovid(R) Pack 600/300" received approval for additional indication for children aged 6 years and older and weighing 20 kg or more - New treatment option for patients infected with COVID-19 -

Antiviral drug "Paquirovid(R) Pack 600/300" received approval for additional indication for children aged 6 years and older and weighing 20 kg or more - New treatment option for patients infected with COVID-19 -

Mar 23, 2026

Shionogi Announces Approval in Japan of a Supplemental Indication for Xocova® (Ensitrelvir Fumaric Acid) for the Post-Exposure Prophylaxis of COVID-19.

Shionogi announced approval in Japan of Xocova (ensitrelvir fumaric acid) for post-exposure prophylaxis of COVID-19 based on positive phase 3 trial results demonstrating prevention of infection.

Mar 20, 2026

COVID-19 Antiviral Use Low in Pregnancy

Pregnant patients were reported to receive antiviral treatment for COVID-19 less often than for influenza despite guideline recommendations.

Mar 18, 2026

Antibiotic used in COVID patients tied to increased signs of antibiotic resistance

A study of hospitalized COVID patients finds use of azithromycin was associated with increased expression of antibiotic resistance genes in the upper airway after only one day of exposure.